Adial Pharmaceuticals Inc (ADIL)
1.25
-0.17
(-11.97%)
USD |
NASDAQ |
May 23, 16:00
1.25
0.00 (0.00%)
After-Hours: 16:12
Adial Pharmaceuticals Cash from Operations (Quarterly): -1.626M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -1.626M |
December 31, 2023 | -1.223M |
September 30, 2023 | -1.391M |
June 30, 2023 | -1.894M |
March 31, 2023 | -2.299M |
December 31, 2022 | -1.751M |
September 30, 2022 | -3.404M |
June 30, 2022 | -3.534M |
March 31, 2022 | -2.497M |
December 31, 2021 | -2.373M |
September 30, 2021 | -3.530M |
June 30, 2021 | -3.203M |
March 31, 2021 | -2.843M |
December 31, 2020 | -2.614M |
September 30, 2020 | -2.208M |
Date | Value |
---|---|
June 30, 2020 | -0.9852M |
March 31, 2020 | -1.825M |
December 31, 2019 | -1.753M |
September 30, 2019 | -1.724M |
June 30, 2019 | -1.140M |
March 31, 2019 | -1.721M |
December 31, 2018 | -1.104M |
September 30, 2018 | -0.9913M |
June 30, 2018 | -0.1889M |
March 31, 2018 | -0.2143M |
December 31, 2017 | -0.1221M |
September 30, 2017 | -0.1368M |
June 30, 2017 | -0.1506M |
March 31, 2017 | -0.0854M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-3.534M
Minimum
Jun 2022
-0.9852M
Maximum
Jun 2020
-2.191M
Average
-2.052M
Median
Cash from Operations (Quarterly) Benchmarks
BioVie Inc | -5.852M |
BioSig Technologies Inc | -1.314M |
Precision BioSciences Inc | -18.98M |
Humacyte Inc | -27.35M |
Monogram Technologies Inc | -3.651M |
Cash from Operations (Quarterly) Related Metrics
Cash from Financing (Quarterly) | 3.824M |
Free Cash Flow | -6.134M |
Free Cash Flow Per Share (Quarterly) | -0.5505 |
Free Cash Flow Yield | -283.4% |